Southland Equity Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Southland Equity Partners's LLY Position: Q2 2026 in Review
Southland Equity Partners increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $84.8K and bringing the position to 693 shares worth $831K. The position accounts for 0.15% of the portfolio, ranked #113.
Southland Equity Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,692 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Southland Equity Partners held 693 shares of Eli Lilly worth $831K as of Q2 2026.
- Southland Equity Partners bought 83 Eli Lilly shares in Q2 2026, an estimated $84.8K.
- Eli Lilly made up 0.15% of Southland Equity Partners's portfolio in Q2 2026, its #113 holding.
- Southland Equity Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 1,692 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.